BIGG

Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children

Lewinsohn, DM; Leonard, MK; LoBue, PA; Cohn, DL; Daley, CL; Desmond, E; Keane, J; Lewinsohn, DA; Loeffler, AM; Mazurek, GH; O'Brien, RJ; Pai, M; Richeldi, L; Salfinger, M; Shinnick, TM; Sterling, TR; Warshauer, DM; Woods, GL.

Clin Infect Dis.; 64 (2), 2017

BACKGROUND: Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuberculosis disease) or may have no clinical evidence of disease (latent tuberculosis infection [LTBI]). Tuberculosis disease is a leading cause of infectious disease morbidity and mortality...

Tuberculosis Pulmonar/diagnóstico, Tuberculosis Latente/diagnóstico, Sensibilidad y Especificidad, Mycobacterium tuberculosis/aislamiento & purificación, Tuberculosis/diagnóstico, Enfoque GRADE, Prueba de Tuberculina, Reproducibilidad de los Resultados, Ensayos de Liberación de Interferón gamma

Texto completo

The use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin

Tuberculosis (TB) remains a large-scale public health problem. Key global priorities for TB care and control include improving case-detection and detecting cases earlier, including cases of smear-negative disease. This document updates existing WHO policy on the use of molecular LPAs for detecting MTBC a...